Back to Search

LYRA

Lyra Therapeutics, Inc. Common Stock
Data: 2026-01-30
$1.78
Price
-9.80%
Change
$37.5
52W High
$0.083
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Quick Stats
Jan 30, 2026

47.9

AI Score

HOLD

0.27

Volume Ratio

Mar 12, 2026

Next Earnings

11

+ve Days (30d)

19

-ve Days (30d)

LYRA Stock Summary

Last updated Jan 30, 2026

LYRA is currently trading at $1.78, positioned below its 200-day moving average of $6.44, suggesting bearish momentum. The stock has a 52-week range of $0.083 to $37.5.

Technical Analysis: The 50-day moving average stands at $3.17, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.689, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.262, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates LYRA at 47.9/100 with a HOLD recommendation.

LYRA (Lyra Therapeutics, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 33.689
CMF (20) 0.262
ROC (10) -8.483
ADX (14) 24.439
Indicator Value
MACD (12,26,9) -0.456
AROONOSC (14) -85.714
WILLAMS %R (14) -81.633
MFI (14) 28.624
LYRA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

LYRA Price vs Max Options Open Interest
LYRA Max Change In Options Open Interest

LYRA Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LYRA Daily Out of Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LYRA Daily In the Money Options - Sort by Max open Interest (near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

LYRA Most Active Options by Volume(near term)

1st February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Lyra Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

LYRA Moving Averages Analysis

LYRA (Lyra Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 2.02
20 2.46
30 2.81
50 3.17
100 4.7
200 6.44

LYRA Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 3.2 million
Earnings/Share ($) -20.37
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -25.66
EPS Estimate Next Year ($) -7.02
WallStreet Target Price ($) 11.5
Most Recent Quarter